A phase I study of lenalidomide in combination with fludarabine and rituximab in previously untreated CLL/SLL.
about
Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)Lenalidomide and chronic lymphocytic leukemiaImmune reconstitution in chronic lymphocytic leukemiaImmunomodulatory drugs and active immunotherapy for chronic lymphocytic leukemiaChronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatmentUpdate on chronic lymphocytic leukemia: overview of new agents and comparative analysis.Lenalidomide inhibits the proliferation of CLL cells via a cereblon/p21(WAF1/Cip1)-dependent mechanism independent of functional p53Treatment with lenalidomide modulates T-cell immunophenotype and cytokine production in patients with chronic lymphocytic leukemiaLenalidomide in the treatment of chronic lymphocytic leukemia.Diagnosis and treatment of chronic lymphocytic leukemia: recommendations from the Brazilian Group of Chronic Lymphocytic Leukemia.New Pharmacotherapies in Chronic Lymphocytic Leukemia.Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approaches.Treating chronic lymphocytic leukemia with thalidomide and lenalidomide.Combination strategies to enhance antitumor ADCC.Lenalidomide alone and in combination for chronic lymphocytic leukemia.Chronic lymphocytic leukemia: 2013 update on diagnosis, risk stratification and treatment.Primary effusion lymphoma in an elderly patient effectively treated by lenalidomide: case report and review of literature.Advances in first-line treatment of chronic lymphocytic leukemia: current recommendations on management and first-line treatment by the German CLL Study Group (GCLLSG).Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment.Bendamustine and rituximab in combination with lenalidomide in patients with chronic lymphocytic leukemia.Fludarabine, cyclophosphamide and lenalidomide in patients with relapsed/refractory chronic lymphocytic leukemia. A multicenter phase I-II GIMEMA trial.Trial Watch: Lenalidomide-based immunochemotherapy.Rhabdomyolysis in a multiple myeloma patient secondary to concurrent treatment with lenalidomide and pravastatin and to lenalidomide alone.
P2860
Q26768154-A5737E72-AEE2-4A38-ADBE-ACCD290B3B43Q26823597-B5FF89D3-C148-47C1-B0F1-CE457F0EE7FAQ26865561-FA2E21CC-1D0B-4501-BE4D-86D228478F4CQ27001318-F643D8A5-7BA4-47A5-95DC-24AFF4E27D22Q28082086-F6BC3804-E7FA-4F5E-934D-A976D279DAF7Q33406478-45F74190-B5AE-4EF4-8DD2-D175062D60ECQ34137016-BD5DD9B0-5868-4D6C-BA1E-5FF2A265E7F2Q35146081-DA47A3AD-E6C5-46D2-8D85-616A09C950D8Q36125070-4FFAEA53-446D-4B0D-94F5-CFBB4E0440E9Q37429218-1B6B1F4C-FC96-487E-8101-91F72E415E55Q37605306-620EAA38-36F0-4C1D-9B62-0C732FD3C548Q37910914-65EA7CE0-EDF7-4485-B37C-2FF0C86A9C8CQ37958036-B8F32ABB-0B0C-40B1-AB59-24A311A6793CQ38014085-2AA690BB-E32B-4F63-B55A-C12BAACD127DQ38068736-D9AC6E0A-B38B-4E67-85BB-ACF5ED934B85Q38110472-93405570-2F1B-4491-808A-5181031DA06CQ38194434-C0B48C3D-E0F0-480C-BD5C-BB4E84EA4B9BQ38579008-DF16836B-9F09-47AD-BF39-365F555C9333Q38646074-5FA7BA19-2F00-422E-8E76-E0F5E7672CD1Q39227223-F60EFC8A-0B8F-483A-B59F-8329B7368B6AQ40438184-1A8ED7D5-FB92-411B-AA35-AD6341CD9A3BQ42737828-3BBF9D67-9C56-46D8-AA81-96BC62BD33E1Q53132147-2FC2F59F-8FCA-44C7-BE31-E8925A7EECA1
P2860
A phase I study of lenalidomide in combination with fludarabine and rituximab in previously untreated CLL/SLL.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
A phase I study of lenalidomid ...... previously untreated CLL/SLL.
@ast
A phase I study of lenalidomid ...... previously untreated CLL/SLL.
@en
type
label
A phase I study of lenalidomid ...... previously untreated CLL/SLL.
@ast
A phase I study of lenalidomid ...... previously untreated CLL/SLL.
@en
prefLabel
A phase I study of lenalidomid ...... previously untreated CLL/SLL.
@ast
A phase I study of lenalidomid ...... previously untreated CLL/SLL.
@en
P2093
P2860
P356
P1433
P1476
A phase I study of lenalidomid ...... previously untreated CLL/SLL.
@en
P2093
A S Freedman
C Thompson
E Hochberg
H Reynolds
J Abramson
P2860
P2888
P304
P356
10.1038/LEU.2010.199
P577
2010-09-16T00:00:00Z
P6179
1010862658